skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

もっと見る

Resources

もっと見る

もっと見る

Products

もっと見る

もっと見る

99+ Total results for product and free and sample content found

世界の薬事規制動向&情報を配信

US COVID Vaccine Patent Waiver Is Big, Symbolic Blow For Pharma, But The Fight Is Just Beginning

JoeBidenwithIndianflaginbackground_1200-1306679316

Drug manufacturers still have a variety of ways to limit the impact of the Biden administration’s historic decision. Whether the huge political loss for industry translates into more than just headline-risk or faster global COVID vaccination remains to be seen. It's also not clear whether it’s an ominous sign for other industry battles in the US, including the drug pricing debate.

Medtech Insight: 世界の医療機器・医療技術の最新情報

Medtech Deal-Making Round Up

Keep current with comprehensive coverage of today’s deals and their impact on the future of the medtech landscape. Medtech Insight brings you insight and analysis of significant recent deals and what they mean for your strategy. Stay in the know with your free Quarterly Roundup.

Topic medtech

HBW Insight : コンシューマーヘルスケア産業のニュース

Germany's OTC Market Struggling To Recover To Pre-Pandemic Levels

German_Coronavirus_1660311100_1200

As Germany remains in lockdown, sales in its OTC market struggle to return to pre-pandemic levels, according to new data from Sempora Consulting. Meanwhile, COVID-related trends for wellness and online shopping endure, indicating some strategic priorities for OTC firms operating in the country. 

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Credit Where It Is Due: Pfizer’s COVID-19 Vaccine Smashes Launch Records As Expected

SC2104_Record_breaking_KP9T6F

Pfizer said it expects to generate $26bn in annual revenues from the COVID-19 vaccine BNT162b2 and is leveraging the platform to build out a durable business.

Minimizing Luck in Study Feasibility

This informative whitepaper introduces you to best practices in study feasibility, which laid the groundwork for our new predictive analytic that is launching soon, Citeline Study Feasibility.  Our industry-leading technology will deliver advanced insight to improve your clinical trial decisions, fast-track enrollment and optimize cycle times – all with less effort.

Topic clinical-trials

Medtech Insight: 世界の医療機器・医療技術の最新情報

Doctor At Center Of Medtronic Meal Kickback Scheme To Pay $4.4M Settlement

MTI2105_Doctor_Bribe_2A0GX32_1200

The settlement resolves allegations the neurosurgeon collected kickbacks both for using Medtronic devices and for buying devices through his own distributorships.

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Will Beovu Be A Slow-Burning Blockbuster?

SC1901_Spy_1155740245_1200

Expanded indications will be key for Novartis's Beovu and a successful diabetic macular edema trial has provided a fillip, a week after the wet AMD-approved drug posted a 44% slump in sales.

Generics Bulletin: ジェネリック&バイオシミラーニュース

Industry Steps Up To Help India Through Second Wave

GB2104_India_flag_covid_2CF9PDG_1200

As India sees a consistent rise in daily cases and deaths due to COVID-19, the off-patent industry is stepping up to make drugs affordable and available. Zydus Cadila is seeking approval for virafin, while Natco has applied for molnupiravir approval. Vaccine production and availability has also come under focus. 

Medtech Insight: 世界の医療機器・医療技術の最新情報

UK Device Regulatory System Off To Good Start Under ‘Supportive’ MHRA

MT2104_UKregsystem_2A8W3X6_1200

The UK’s new medical device registration system, one element of the post-Brexit transition being overseen by the MHRA, is going more or less to plan in the early stages of the standstill period.

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

新型コロナウイルス感染拡大防止のため在宅勤務を実施しています。お問い合わせの際は下記のフォームまたはメールアドレスをご利用下さい。

Eメール:inquiry.jp@informa.com


オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。